Boiron SA (OTCMKTS:BOIRF – Get Free Report) saw a significant growth in short interest in April. As of April 30th, there was short interest totaling 27 shares, a growth of ∞ from the April 15th total of 0 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.
Boiron Price Performance
Shares of OTCMKTS BOIRF opened at $30.00 on Monday. Boiron has a 12-month low of $24.00 and a 12-month high of $32.28. The firm’s 50-day moving average is $30.00 and its two-hundred day moving average is $30.07.
Boiron Company Profile
Boiron (OTCMKTS: BOIRF) is a France-based manufacturer and distributor of homeopathic medicines. Established in 1932 by the Boiron brothers in Lyon, the company has grown into a global leader in homeopathy, offering a wide range of over 200 medicines designed for self-medication. Boiron’s portfolio addresses common ailments such as colds, flu-like symptoms, muscle soreness and teething discomfort, underscoring its focus on accessible, non-prescription treatments.
The company’s products are formulated in various forms, including pellets, tablets, gels, creams, ointments and nasal sprays.
Read More
- Five stocks we like better than Boiron
- As U.S. Debt Surpasses GDP, These 2 ETFs Are Emerging Winners in the “Sell America” Trade
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
Receive News & Ratings for Boiron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boiron and related companies with MarketBeat.com's FREE daily email newsletter.
